Home>Topics>Companies>AptarGroup

AptarGroup ATR

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Headlines
    1. New Morningstar Analyst Report for AptarGroup , Inc.

      Stock Reports

      Tue, 22 Jul 2014

      There have been many dispensing innovations in recent years, particularly in the consumer goods space, so we may have passed the peak of the current replacement cycle.Some pharmaceutical companies have taken drug delivery development in-house. If that trend intensifies, it could result in lower

    2. A Weak U.S. Consumer Weighs on Aptar's Results; Narrow Economic Moat Remains Intact

      Commentary

      Tue, 22 Jul 2014

      After reviewing AptarGroup 's second-quarter results, we are maintaining our $70 per share fair value estimate and our narrow economic moat rating

    3. AptarGroup updates guidance after Q2 results

      Headlines

      Mon, 21 Jul 2014

      AptarGroup ( ATR -1% ) Q2 results : Total Revenues: $670.6M (+4.6%), Beauty + Home: $385.2M (+2.7%), Pharma: $195

    4. AptarGroup misses by $0.03, misses on revenue

      Headlines

      Mon, 21 Jul 2014

      AptarGroup (NYSE: ATR ): Q2 EPS of $0.79 misses by $0.03 . Revenue of $670.63M (+4.6% Y/Y) misses by $13.31M . Press Release Post your comment!

    5. AptarGroup , Inc. declares $0.28 dividend

      Headlines

      Thu, 17 Jul 2014

      AptarGroup Inc. (NYSE: ATR ) declares $0.28/share quarterly dividend , in line with previous. Forward yield 1.72% Payable Aug. 20; for shareholders of record July 30; ex-div July 28. Post your comment!

    6. Increasing AptarGroup's Fair Value Estimate to $70 Per Share

      Commentary

      Mon, 28 Apr 2014

      After reviewing AptarGroup 's first-quarter report, we're increasing our fair value estimate to $70 per share from $66, due primarily to an improved

    7. Aptar Turns in Another Steady Quarter; Renewed Beauty & Home Demand is Encouraging

      Commentary

      Fri, 25 Apr 2014

      After reviewing AptarGroup 's first-quarter report, we expect to slightly increase our fair value estimate of $66 per share due primarily to an improved

    8. Narrow-Moat Aptar's Pharmaceutical Division Continues to Shine; Increasing Our Fair Value Estimate

      Commentary

      Fri, 7 Feb 2014

      After reviewing AptarGroup 's fourth-quarter and full-year results, we are increasing our fair value estimate to $66 per share from $60 per share

    9. Narrow-Moat Aptar Has Exemplary Stewardship

      Headlines

      Fri, 15 Nov 2013

      AptarGroup ATR might be a lesser-known name in the packaging industry, but it's one to get to know. Its dispensing niche has proved

    10. Aptar's 3Q Driven by Strong Sales to the Consumer Health and Injection Markets

      Commentary

      Thu, 31 Oct 2013

      After reviewing AptarGroup 's third-quarter results, we are increasing our fair value estimate to $60 per share from $58 per share due to a slightly

    « Prev123Next »
    Content Partners